1. Zhou, Wei, Ma, Dongrui, Tan, Eng-King. 2019. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications. In The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 26, 170-184. doi:10.1177/1073858419871214. https://pubmed.ncbi.nlm.nih.gov/31526091/
2. Zhou, QingQing, Chen, YongPing, Wei, QianQian, Hadano, Shinji, Shang, Hui-Fang. 2016. Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis. In Molecular neurobiology, 54, 3189-3194. doi:10.1007/s12035-016-9888-0. https://pubmed.ncbi.nlm.nih.gov/27056076/
3. Li, Xiao Ling, Shu, Shi, Li, Xiao Guang, Cui, Li Ying, Zhang, Xue. 2016. CHCHD10 is not a frequent causative gene in Chinese ALS patients. In Amyotrophic lateral sclerosis & frontotemporal degeneration, 17, 458-60. doi:10.3109/21678421.2016.1170151. https://pubmed.ncbi.nlm.nih.gov/27077676/
4. Xia, Wei, Qiu, Jiamin, Peng, Ying, Yue, Feng, Kuang, Shihuan. 2022. Chchd10 is dispensable for myogenesis but critical for adipose browning. In Cell regeneration (London, England), 11, 14. doi:10.1186/s13619-022-00111-0. https://pubmed.ncbi.nlm.nih.gov/35362877/
5. Liu, Tian, Woo, Jung-A A, Bukhari, Mohammed Zaheen, Zhao, Xingyu, Kang, David E. 2020. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34, 8493-8509. doi:10.1096/fj.201903133RR. https://pubmed.ncbi.nlm.nih.gov/32369233/
智鼠故事 
